Pralidoxime
The Department of National Defence is procuring pralidoxime—specifically pralidoxime chloride or pralidoxime methyl sulfate—to support the Canadian Forces Health Services Group in treating armed force* ********* *** *** ** ******* ** ******** ******* ******* *** ******* *********** ***** *** ******** ** ***** ********* ***** ** ************** **** ** ******** ********* ** ** ** ***** ********** ***** ********* *** ******** ******* ************ *** ************** ******** **** ** ********* ** *** ********** ***** ********* ** *** ********** ********* **** *********** **** ** ******** ***** *** ***** **** ********** ******* ********* ******** **** ** ******** ************ ***** ** **** **************** ***** ***** ********** ******** ********** * ************** ****** ********* ** ******** ******* ******* **************** ********* **** *** ******* ** ** * **** ******** *** ********* ******* ************ *** ************* ****** *** ****** ** *** *** *********** ****** *** ******** ********** **** *********** ************** ********** *************** ********** ********** *** ********** ********* ** ************** ********** *********** ***** *** **************** ******** ************ *** ********** **** **** *** ********** ********** *** ** ******** ** ********** ** ********** ***********
Want to unlock the full information?
Member-only information. Become a member to access this information.
Procurement notices from more than 200 sources and banks are available here
Details
Status:
Closed
Sectors:
33000000 - Medical equipments, pharmaceuticals and personal care products
Place of origin:
Canada
Deadline:
Jan 22, 2026 19:00
Contract type:
Member-only information
Publication date:
Member-only information
Created date:
Member-only information
Stored documents
Member-only information
Document Retrieval Guide
Member-only information
Original URL:
Member-only information
Contracting Entities
Member-only information